News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
19,862 Results
Type
Article (936)
Company Profile (2)
Press Release (18924)
Section
Business (11113)
Career Advice (11)
Deals (1329)
Drug Development (1957)
FDA (335)
Job Trends (376)
News (14130)
Policy (608)
Tag
Academia (27)
Allergies (1)
Alliances (772)
ALS (15)
Alzheimer's disease (18)
Antibody-drug conjugate (ADC) (3)
Approvals (335)
Artificial intelligence (1)
Bankruptcy (8)
Best Places to Work (309)
Biotechnology (1)
Bladder cancer (1)
Brain cancer (1)
Breast cancer (2)
Cancer (39)
Cardiovascular disease (1)
Career advice (11)
Cell therapy (3)
Clinical research (1715)
Collaboration (6)
Compensation (2)
COVID-19 (35)
C-suite (1)
Data (80)
Diabetes (5)
Diagnostics (199)
Digital health (1)
Duchenne muscular dystrophy (3)
Earnings (10022)
Events (1096)
FDA (390)
Frontotemporal dementia (1)
Funding (11)
Gene editing (2)
Gene therapy (3)
GLP-1 (17)
Government (36)
Guidances (46)
Healthcare (452)
Immunology and inflammation (3)
Indications (1)
Infectious disease (35)
Inflammatory bowel disease (2)
Intellectual property (1)
IPO (960)
Job creations (95)
Job search strategy (10)
Labor market (2)
Layoffs (5)
Legal (110)
Lung cancer (12)
Lymphoma (4)
Manufacturing (4)
MASH (1)
Medical device (460)
Medtech (460)
Mergers & acquisitions (369)
Metabolic disorders (17)
Multiple sclerosis (3)
Neurodegenerative disease (2)
Neuroscience (43)
NextGen: Class of 2025 (108)
Non-profit (31)
Now hiring (1)
Obesity (10)
Opinion (4)
Pancreatic cancer (2)
Parkinson's disease (6)
Patents (3)
Peanut (1)
People (721)
Phase I (371)
Phase II (714)
Phase III (698)
Pipeline (185)
Policy (1)
Postmarket research (97)
Preclinical (169)
Prostate cancer (1)
Radiopharmaceuticals (3)
Rare diseases (2)
Real estate (113)
Regulatory (478)
Reports (1)
Research institute (33)
Resumes & cover letters (2)
Schizophrenia (1)
Series A (1)
Spinal muscular atrophy (4)
Startups (35)
Vaccines (6)
Weight loss (6)
Date
Today (7)
Last 7 days (63)
Last 30 days (121)
Last 365 days (1144)
2025 (425)
2024 (1262)
2023 (1436)
2022 (1515)
2021 (1555)
2020 (1330)
2019 (883)
2018 (704)
2017 (6628)
2016 (385)
2015 (549)
2014 (327)
2013 (178)
2012 (246)
2011 (311)
2010 (313)
Location
Africa (15)
Arizona (6)
Asia (1392)
Australia (126)
California (208)
Canada (63)
China (16)
Colorado (9)
Connecticut (9)
Delaware (8)
Europe (2801)
Florida (31)
Georgia (5)
Idaho (2)
Illinois (17)
India (1)
Indiana (19)
Japan (5)
Kansas (3)
Kentucky (1)
Louisiana (3)
Maine (2)
Maryland (28)
Massachusetts (155)
Michigan (10)
Minnesota (19)
Montana (3)
Nevada (2)
New Hampshire (4)
New Jersey (73)
New York (62)
North Carolina (25)
Northern California (114)
Ohio (6)
Oregon (1)
Pennsylvania (56)
South America (38)
Southern California (74)
Tennessee (2)
Texas (27)
United States (802)
Utah (10)
Virginia (3)
Washington State (20)
Wisconsin (1)
19,862 Results for "167".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Emergent BioSolutions Receives Contract Option Valued at Approximately $16.7 Million to Continue Development Collaboration with BARDA on Ebanga™ (ansuvimab-zykl) Treatment for Ebola
January 14, 2025
·
6 min read
Business
Updated: Artiva’s IPO Jumps to $167M
Cell therapy biotech Artiva Biotherapeutics plans to use the funds raised to support the development of its AlloNK therapy for systemic lupus erythematosus.
July 19, 2024
·
2 min read
·
Tyler Patchen
Business
Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering
July 18, 2024
·
3 min read
Press Releases
OcuMension acquires rights to Alcon eye drops in exchange for a 16.7% equity stake, signaling the commencement of comprehensive strategic relationship
August 12, 2024
·
3 min read
BioCapital
Landos Biopharma Announces $16.7 Million Private Placement Financing
Landos Biopharma, Inc. announced a $16.7 million private placement financing from the sale of pre-funded warrants to purchase an aggregate of 30,909,090 shares of its common stock at a price per pre-funded warrant of $0.54 to entities associated with Perceptive Advisors LLC, Landos’ largest stockholder.
January 5, 2023
·
4 min read
BioCapital
$1.67M NIH Grant Brings Scene Health’s Medication Support to Florida Pediatric Heart Transplant Centers
Children who need life-changing heart transplants in Florida will be able to receive free support to help improve medication adherence, which can potentially reduce the frequency of organ rejection over the next two years, thanks to a National Institutes of Health /National Heart Lung and Blood Institute Small Business Innovation Research award for $1.67M to Scene Health, a leading video medication adherence platform.
April 6, 2023
·
5 min read
Medical Device Contract Manufacturing Market Size Will Attain USD 167.34 Bn By 2030
The global medical device contract manufacturing market size accounted for 72.89 billion in 2022 and would grow to USD 167.34 billion by 2030, with a remarkable CAGR of 10.9% between 2022 and 2030.
October 19, 2022
·
7 min read
Infectious Disease Therapeutics Market Size To Surpass USD 167 BN By 2030
The global Infectious Disease Therapeutics market size was estimated at USD 115 billion in 2021 and is expected to surpass around USD 167 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 4.23% during the forecast period 2022 to 2030.
September 13, 2022
·
9 min read
Infectious Disease Therapeutics Market Size To Surpass USD 167 BN By 2030
The global Infectious Disease Therapeutics market size was estimated at USD 115 billion in 2021 and is expected to surpass around USD 167 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 4.23% during the forecast period 2022 to 2030.
September 12, 2022
·
9 min read
BioCapital
Clinical Chemistry Impact Factor Rises to 12.167, the Highest in the History of the Journal
AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce that the impact factor of its journal Clinical Chemistry has risen to 12.167 in the 2021 Clarivate Journal Citation Reports.
June 30, 2022
·
2 min read
1 of 1,987
Next